Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Replicel Life Sciences Inc V.RP

Alternate Symbol(s):  REPCF

RepliCel Life Sciences Inc. is a Canada-based regenerative medicine company. The Company is focused on developing cell therapies for aesthetic and orthopedic conditions, including aging/sun-damaged skin, pattern baldness, and chronic tendon degeneration. The Company’s cell therapy product pipeline is comprised of RCT-01 for tendon repair, RCS-01 for skin rejuvenation, and RCH-01 for hair restoration. RCH-01 is an autologous cell therapy utilizing dermal sheath cup (DSC) cells isolated from the hair follicle to treat androgenetic alopecia. RCS-01 is an autologous cell therapy utilizing non-bulbar dermal sheath (NBDS) cells, a type of fibroblast cell isolated from the hair follicle to repair and regenerate tissue. RCT-01 provides a source of collagen expressing cells to the site of injury, addressing the underlying cause of tendinosis. It has also developed an injection device, DermaPrecise, which improves the administration of its cell therapy products and certain other injectables.


TSXV:RP - Post by User

Comment by Ingiboyon May 03, 2024 12:22pm
88 Views
Post# 36021881

RE:money

RE:money
bluemoons20 wrote: Question,
Been away  for  awhile.  have not  followed  what is  unfolding.  See something about  Andrew  lending comany some  money?   Why do we need it.  He  bought a ton  of  shares.  Where did all that money go??  the company  did not  spend it  on  any  research  or development?   Ws th money  just  to pay  himself .  Kind of  having your cake and eating it??

GLTA


This so called loan by Andrew Schutte is yet another reinforcement of his attempt to take total control of the company. From the NR of April 17th:

"The loan will be secured against all present and after-acquired property of RepliCel, pursuant to the terms of a general security agreement dated April 10, 2024."

He would be first creditor in line for any sale of assets before the shareholders.  Also this loan of $1,000,000 has 5% interest and matures in 12 months after the first loan payment.

Are you guys following all this ?   It is like putting a pea under 3 shells and try to follow where the pea is when the shells are shuffled......total BS.  We are and will be screwed on this. 

<< Previous
Bullboard Posts
Next >>